Regulatory · source year

2013 regulatory records

12 selected, source-linked regulatory records dated 2013. This is selective source coverage, not a complete timeline.

Dated records

12 selected records.

Peptide profiles

7 connected profiles.

Cited sources

12 distinct public records.

Cited chronology

Dated source records

All record types in 2013 →

December 2013

1 record

November 2013

2 records

October 2013

1 record

Metreleptin

Federal Register notice 2013-25588

The Federal Register published notice 2013-25588, attributed to FDA and its parent HHS department, on 2013-10-30. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Metreleptin.

Source: Federal Register via GovInfo ↗

→

August 2013

1 record

April 2013

2 records

Oxytocin

Federal Register rule 2013-07542

The Federal Register published rule 2013-07542, attributed to FDA and its parent HHS department, on 2013-04-09. Its official title is “New Animal Drugs; Change of Sponsor,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.

Source: Federal Register via GovInfo ↗

→

March 2013

2 records

Oxytocin

Federal Register rule 2013-06126

The Federal Register published rule 2013-06126, attributed to FDA and its parent HHS department, on 2013-03-22. Its official title is “New Animal Drugs; Changes of Sponsor,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.

Source: Federal Register via GovInfo ↗

→

Sermorelin

Federal Register notice 2013-04827

The Federal Register published notice 2013-04827, attributed to FDA and its parent HHS department, on 2013-03-04. Its official title is “Determination That GEREF (Sermorelin Acetate) Injection, 0.5 Milligrams Base/Vial and 1.0 Milligrams Base/Vial, and GEREF (Sermorelin Acetate) Injection, 0.05 Milligrams Base/Amp, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Sermorelin.

Source: Federal Register via GovInfo ↗

→

February 2013

1 record

January 2013

2 records

Calcitonin salmon

Federal Register notice 2013-00507

The Federal Register published notice 2013-00507, attributed to FDA and its parent HHS department, on 2013-01-14. Its official title is “Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon.

Source: Federal Register via GovInfo ↗

→